| 000 | 01672 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515164223.0 | ||
| 264 | 0 | _c20090612 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1175-3277 | ||
| 024 | 7 |
_a10.1007/BF03256579 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhao, Jing-Lin | |
| 245 | 0 | 0 |
_aThe effect of statins on the no-reflow phenomenon: an observational study in patients with hyperglycemia before primary angioplasty. _h[electronic resource] |
| 260 |
_bAmerican journal of cardiovascular drugs : drugs, devices, and other interventions _c2009 |
||
| 300 |
_a81-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 | _aCoronary Angiography |
| 650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
| 650 | 0 | 4 | _aEchocardiography |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aHyperglycemia _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdiagnostic imaging |
| 650 | 0 | 4 |
_aNo-Reflow Phenomenon _xcomplications |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 700 | 1 | _aYang, Yue-Jin | |
| 700 | 1 | _aPei, Wei-Dong | |
| 700 | 1 | _aSun, Yu-Hua | |
| 700 | 1 | _aChen, Ji-Lin | |
| 773 | 0 |
_tAmerican journal of cardiovascular drugs : drugs, devices, and other interventions _gvol. 9 _gno. 2 _gp. 81-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF03256579 _zAvailable from publisher's website |
| 999 |
_c18767886 _d18767886 |
||